Medical Affairs
Innoviva Specialty Therapeutics has created this website as a tool for healthcare professionals in the United States. The information presented on this platform is solely for informational purposes and is not meant to advertise or endorse the use of any particular product.
For medical inquiries, please contact medinfo@istx.com.
Medical Information Request
If you have a question about an Innoviva Specialty Therapeutics product and would like to speak with a medical information specialist, please call 1-800-651-3861 (Monday to Friday, 9 AM to 5 PM ET, excluding holidays) or email medinfo@istx.com. If you have a medical emergency, dial 911 for immediate assistance.
Our marketed products are GIAPREZA® (angiotensin II) and XERAVA® (eravacycline)
Our investigational therapies are Sulbactam-durlobactam and Zoliflodacin
Publications
For publications about products, please visit the links below:
GIAPREZA® (angiotensin II)
View publications
XERAVA® (eravacycline)
View publications
Sulbactam-durlobactam
View publications
Zoliflodacin
View publications
Request Follow-up from a Medical Science Liaison
If you would like additional information about our products or would like to discuss research ideas, please contact medinfo@istx.com.
Report an Adverse Event
To report an Adverse Event, please use the appropriate product contact below. You can also contact the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
To report an Adverse Event for XERAVA® (eravacycline):
Email tphasemedinfo@ljpc.com or call us 1-833-7-XERAVA (1-833-793-7282)
To report an Adverse Event for GIAPREZA® (angiotensin II):
Email medicalinformation@ljpc.com or call us 1-800-651-3861
You are entering Medical Affairs
The purpose of this website is to serve as an educational tool for healthcare professionals who practice in the United States. The information presented on this platform is solely for informational purposes and is not intended to encourage the use of any particular product. It is advised that healthcare professionals review the corresponding package insert to obtain safety information and instructions on the use of medications before prescribing them.
Are you a health professional practicing in the United States?